(Health-NewsWire.Net, October 02, 2017 ) According to Publisher, the Global Active Pharmaceutical Ingredients market is expected to grow from $129.12 billion in 2015 to reach $198.8 billion by 2022 with a CAGR of 6.4%. Patent expiration of prominent drugs, government initiatives, regional penetration and increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth. For more information @ http://www.reportsweb.com/active-pharmaceutical-ingredients-global-market-outlook-2016-2022
Some of the key players in global Active Pharmaceutical Ingredients market include Bioniche Animal Health (Canada), Boehringer Ingelheim (Germany), Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Bayer Healthcare (Germany), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Ceva Animal Health, Inc., Dr. Reddy's Laboratories Ltd., Novartis International AG, Ranbaxy Laboratories, Virbac, Zoetis (U.S.), Pfizer, Inc, Aurobindo Pharma Ltd., and Heska Co. (U.S.)
Types of API Covered: - Synthetic chemical API o Branded/ Innovative o Generic/Non- Branded - Biological API o Biotech o Biosimilar - High potency active pharmaceutical ingredients(HPAPI) Types of Manufacturing Covered: - Captive (or in-house) manufacturing - Contract manufacturing
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001583393/sample Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001583393/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|